Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Volkenandt

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Archives of Dermatological Research|October 31, 2006
Variations of the melanocortin-1 receptor and the glutathione-S transferase T1 and M1 genes in cutaneous malignant melanomaRotraut Mössner, Nils Anders, Inke R König, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 3, 2009
Depressive mood changes and psychiatric symptoms during 12-month low-dose interferon-alpha treatment in patients with malignant melanoma: results from the multicenter DeCOG trialSarah Heinze, Friederike Egberts, Susanne Rötzer, et al.
Journal of Cutaneous Pathology|March 19, 2003
Loss of expression of tuberin and hamartin in tuberous sclerosis complex-associated but not in sporadic angiofibromasIngrid Fackler, Jeffrey E DeClue, Heidi Rust, et al.
Acta Oncologica (Stockholm, Sweden)|June 9, 2006
Long-term survival benefit after adjuvant treatment of cutaneous melanoma with dacarbazine and low dose natural interferon alpha: A controlled, randomised multicentre trialRudolf Stadler, Thomas Luger, Thomas Bieber, et al.
Archives of Dermatological Research|May 12, 2012
No association of vitamin D metabolism-related polymorphisms and melanoma risk as well as melanoma prognosis: a case-control studyAnnika Schäfer, Steffen Emmert, Jochen Kruppa, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 28, 2006
[Brief guidelines: malignant melanoma of the skin]Claus Garbe, Axel Hauschild, Matthias Volkenandt, et al.
European Journal of Human Genetics : EJHG|October 21, 2004
No association between three xeroderma pigmentosum group C and one group G gene polymorphisms and risk of cutaneous melanomaSandra Blankenburg, Inke R König, Rotraut Moessner, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 19, 2011
Health-related quality of life before and during adjuvant interferon-α treatment for patients with malignant melanoma (DeCOG-trial)Susanne Ziefle, Friederike Egberts, Sarah Heinze, et al.
Melanoma Research|November 10, 2007
Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanomaClaus Garbe, Axel Hauschild, Matthias Volkenandt, et al.
Melanoma Research|March 14, 2008
Evidence-based and interdisciplinary consensus-based German guidelines: systemic medical treatment of melanoma in the adjuvant and palliative settingClaus Garbe, Axel Hauschild, Matthias Volkenandt, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Archives of Dermatological Research|October 31, 2006
Variations of the melanocortin-1 receptor and the glutathione-S transferase T1 and M1 genes in cutaneous malignant melanomaRotraut Mössner, Nils Anders, Inke R König, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 3, 2009
Depressive mood changes and psychiatric symptoms during 12-month low-dose interferon-alpha treatment in patients with malignant melanoma: results from the multicenter DeCOG trialSarah Heinze, Friederike Egberts, Susanne Rötzer, et al.
Journal of Cutaneous Pathology|March 19, 2003
Loss of expression of tuberin and hamartin in tuberous sclerosis complex-associated but not in sporadic angiofibromasIngrid Fackler, Jeffrey E DeClue, Heidi Rust, et al.
Acta Oncologica (Stockholm, Sweden)|June 9, 2006
Long-term survival benefit after adjuvant treatment of cutaneous melanoma with dacarbazine and low dose natural interferon alpha: A controlled, randomised multicentre trialRudolf Stadler, Thomas Luger, Thomas Bieber, et al.
Archives of Dermatological Research|May 12, 2012
No association of vitamin D metabolism-related polymorphisms and melanoma risk as well as melanoma prognosis: a case-control studyAnnika Schäfer, Steffen Emmert, Jochen Kruppa, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 28, 2006
[Brief guidelines: malignant melanoma of the skin]Claus Garbe, Axel Hauschild, Matthias Volkenandt, et al.
European Journal of Human Genetics : EJHG|October 21, 2004
No association between three xeroderma pigmentosum group C and one group G gene polymorphisms and risk of cutaneous melanomaSandra Blankenburg, Inke R König, Rotraut Moessner, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 19, 2011
Health-related quality of life before and during adjuvant interferon-α treatment for patients with malignant melanoma (DeCOG-trial)Susanne Ziefle, Friederike Egberts, Sarah Heinze, et al.
Melanoma Research|November 10, 2007
Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanomaClaus Garbe, Axel Hauschild, Matthias Volkenandt, et al.
Melanoma Research|March 14, 2008
Evidence-based and interdisciplinary consensus-based German guidelines: systemic medical treatment of melanoma in the adjuvant and palliative settingClaus Garbe, Axel Hauschild, Matthias Volkenandt, et al.
Pageof 4